IBD Stock Of The Day: Genetics Firm Breaks Out On Cancer Testing Trends [Investor's Business Daily]
Myriad Genetics, Inc. (MYGN)
Last myriad genetics, inc. earnings: 2/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
myriad.com/news-center/investor-information
Company Research
Source: Investors Business Daily
Related news Myriad Genetics ( MYGN ) is the IBD Stock Of The Day after it broke out Wednesday on an analyst upgrade noting trends in genetic cancer tests are improving. Myriad stock spiked 14.7%, near 43.60, in midday trading on the stock market today after Morgan Stanley analyst Steve Beuchaw upgraded it to an overweight rating from equal weight. Beuchaw also boosted his price target to 55 from 35. Shares surged past a buy point at 40.82 out of a cup-with-handle base in heavy volume . In midday action, they were about 6% extended from that point. This followed a brief breakout on June 18 out of a cup-with-handle at 40. Myriad's core business is selling tests to determine whether a patient carries a genetic risk of developing cancer. As those core sales stabilize, Myriad's high return on capital deployment could help earnings accelerate, Beuchaw said. "We believe Myriad Genetics' earnings profile is dramatically changing," he said in a report to clients. "The core (hereditary cancer
Show less
Read more
Impact Snapshot
Event Time:
MYGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MYGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MYGN alerts
High impacting Myriad Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
MYGN
News
- Why Is Myriad (MYGN) Down 1% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Myriad Genetics (MYGN) Wins Foundational Patent for MRD Assay [Yahoo! Finance]Yahoo! Finance
- Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date [Yahoo! Finance]Yahoo! Finance
- Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority DateGlobeNewswire
- Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device [Yahoo! Finance]Yahoo! Finance
MYGN
Earnings
- 2/27/24 - Beat
MYGN
Sec Filings
- 3/28/24 - Form 4/A
- 3/27/24 - Form 4
- 3/25/24 - Form 4
- MYGN's page on the SEC website